Compare LXU & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXU | NNNN |
|---|---|---|
| Founded | 1968 | 2021 |
| Country | United States | Germany |
| Employees | 513 | 27 |
| Industry | Major Chemicals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2006 | N/A |
| Metric | LXU | NNNN |
|---|---|---|
| Price | $12.39 | $34.85 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.63 | N/A |
| AVG Volume (30 Days) | ★ 965.5K | 14.9K |
| Earning Date | 04-29-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.93 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $615,208,000.00 | N/A |
| Revenue This Year | $13.69 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $47.89 | $446.57 |
| Revenue Growth | ★ 17.77 | N/A |
| 52 Week Low | $7.09 | $7.76 |
| 52 Week High | $17.22 | $55.65 |
| Indicator | LXU | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 36.89 | 66.49 |
| Support Level | $8.15 | $26.31 |
| Resistance Level | $15.56 | $44.06 |
| Average True Range (ATR) | 0.68 | 3.05 |
| MACD | -0.19 | 0.66 |
| Stochastic Oscillator | 0.16 | 90.43 |
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).